Dr. Varadarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
910 Madison Ave
Fl 2
Memphis, TN 38103Phone+1 901-448-5914
Education & Training
Wayne State University School of MedicineClass of 2019
Publications & Presentations
PubMed
- Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa M McShane
Molecular Cancer Therapeutics. 2024-07-02 - Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat
Cancer Discovery. 2024-05-01 - 9 citationsConvergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.Timothy P DiPeri, Ming Zhao, Kurt W Evans, Kaushik Varadarajan, Tyler Moss
Journal of Hepatology. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
